Wake Up Narcolepsy Debuts Public Service Announcement

Avadel Pharmaceuticals Announces Final FDA Approval of LUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension as the First and Only Once-at-Bedtime Oxybate for Cataplexy or Excessive Daytime Sleepiness in Adults with Narcolepsy

Zerva Therapeutics Announces Submission of IND for KP1077 in Narcolepsy

Jazz Pharmaceuticals Expands Support of the American Heart Association to Raise Awareness of the Link Between Sleep Disorders and Heart Health

Harmony Biosciences Community-Facing Statement

Max’s Story: Conquering Narcolepsy

NLS Pharmaceutics Provides Open Label Extension Study Update for Quilience® (Mazindol ER) in the Treatment of Narcolepsy

Wake Up Narcolepsy announces its media partnership with Red Square Pictures

Webinar with Dr. Gary Zammit, President and CEO of Clinilabs Drug Development Corporation

WUN’s Impact on Narcolepsy Research